ISRG has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ISRG has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Intuitive Surgical's Enterprise Value is $128,952 Mil. Intuitive Surgical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $1,849 Mil. Therefore, Intuitive Surgical's EV-to-EBIT ratio for today is 69.76.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Intuitive Surgical's Enterprise Value is $128,952 Mil. Intuitive Surgical's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was $2,287 Mil. Therefore, Intuitive Surgical's EV-to-EBITDA ratio for today is 56.38.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Intuitive Surgical's Enterprise Value is $128,952 Mil. Intuitive Surgical's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $7,319 Mil. Therefore, Intuitive Surgical's EV-to-Revenue ratio for today is 17.62.
The historical data trend for Intuitive Surgical's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intuitive Surgical Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Enterprise Value | Get a 7-Day Free Trial | 65,372.60 | 91,146.47 | 124,341.11 | 88,825.30 | 113,718.43 |
Intuitive Surgical Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Enterprise Value | Get a 7-Day Free Trial | 84,900.99 | 114,404.92 | 96,494.88 | 113,718.43 | 136,840.92 |
For the Medical Instruments & Supplies subindustry, Intuitive Surgical's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Intuitive Surgical's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Intuitive Surgical's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Intuitive Surgical's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
Enterprise Value (A: Dec. 2023 ) | |||||
= | Market Cap | + | Preferred Stock | + | Long-Term Debt & Capital Lease Obligation |
= | 118851.928 | + | 0 | + | 0 |
+ | Short-Term Debt & Capital Lease Obligation | + | Minority Interest | - | Cash, Cash Equivalents, Marketable Securities |
+ | 0 | + | 89.7 | - | 5223.2 |
= | 113,718 |
Intuitive Surgical's Enterprise Value for the quarter that ended in Mar. 2024 is calculated as
Enterprise Value (Q: Mar. 2024 ) | |||||
= | Market Cap | + | Preferred Stock | + | Long-Term Debt & Capital Lease Obligation |
= | 141557.223 | + | 0 | + | 0 |
+ | Short-Term Debt & Capital Lease Obligation | + | Minority Interest | - | Cash, Cash Equivalents, Marketable Securities |
+ | 0 | + | 83.8 | - | 4800.1 |
= | 136,841 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intuitive Surgical (NAS:ISRG) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Intuitive Surgical's EV-to-EBIT for today is
EV-to-EBIT | = | Enterprise Value (Today) | / | EBIT (TTM) |
= | 128952.371 | / | 1848.6 | |
= | 69.76 |
Intuitive Surgical's current Enterprise Value is $128,952 Mil.
Intuitive Surgical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,849 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Intuitive Surgical's EV-to-EBITDA for today is:
EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA(TTM) |
= | 128952.371 | / | 2287 | |
= | 56.38 |
Intuitive Surgical's current Enterprise Value is $128,952 Mil.
Intuitive Surgical's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,287 Mil.
3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.
Intuitive Surgical's EV-to-Revenue for today is:
EV-to-Revenue | = | Enterprise Value (Today) | / | Revenue (TTM) |
= | 128952.371 | / | 7318.5 | |
= | 17.62 |
Intuitive Surgical's current Enterprise Value is $128,952 Mil.
Intuitive Surgical's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $7,319 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Intuitive Surgical's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Alan J Levy | director | C/O INTUITIVE SURGICAL INC, 1266 KIFER RD, SUNNYVALE CA 94086 |
Robert Desantis | officer: Executive VP & GM IA&E | C/O INTUITIVE SURGICAL, INC., 1020 KIFER ROAD, SUNNYVALE CA 94086 |
Sreelakshmi Kolli | director | C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131 |
Gary S Guthart | director, officer: President & CEO, other: President & CEO | C/O INTUITIVE SURGICAL INC, 1266 KIFER RD, SUNNYVALE CA 94086 |
Amy L Ladd | director | INTUITIVE SURGICAL, INC, 1020 KIFER RD, SUNNYVALE CA 94086 |
Craig H Barratt | director | |
Marshall Mohr | officer: SVP & CFO | C/O INTUITIVE SURGICAL, INC, 1266 KIFER ROAD, SUNNYVALE CA 94086 |
Mark J Rubash | director | |
David J. Rosa | officer: Sr VP Emerging Procedures & Te | 1266 KIFER ROAD, SUNNYVALE CA 94086 |
Fredrik Widman | officer: VP Corporate Controller | 1020 KIFER ROAD, 1020 KIFER ROAD, SUNNYVALE CA 94086 |
Myriam Curet | officer: SVP & Chief Medical Officer, other: SVP & Chief Medical Officer | 1020 KIFER ROAD, SUNNYVALE CA 94086 |
Michele Dimartino | officer: See Remarks | 1020 KIFER ROAD, SUNNYVALE CA 94086 |
Amal M Johnson | director | C/O MELLANOX TECHNOLOGIES, INC., 350 OAKMEAD PARKWAY, SUITE 100, SUNNYVALE CA 94085 |
Gary Loeb | officer: General Counsel & CCO | 5885 HOLLIS ST., SUITE 100, EMERYVILLE CA 94608 |
Henry L Charlton | officer: Senior Vice President & Chief | 1020 KIFER ROAD, 1020 KIFER ROAD, SUNNYVALE CA 94086 |
From GuruFocus
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
By GuruFocus Research • 01-23-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.